[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100621041":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":28,"centralContacts":32,"locations":38,"responsibleParty":195,"collaborators":25,"id":197,"slug":198,"hasResults":199,"nctId":200,"briefTitle":201,"officialTitle":202,"acronym":25,"eligibilityCriteria":203,"healthyVolunteers":199,"sex":204,"minAge":205,"maxAge":206,"enrollmentInfo":207,"targetDuration":25,"studyType":210,"phases":211,"briefSummary":213,"conditions":214,"keywords":216,"overallStatus":41,"whyStopped":25,"lastUpdateSubmitDate":217,"lastUpdatePostDateStruct":218,"startDateStruct":221,"completionDateStruct":223,"leadSponsor":225,"locationsCount":226},{"fullName":5,"class":6},"Neurocrine Biosciences","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"NBI-1065890","EXPERIMENTAL","Participants will receive NBI-1065890.",[13],"Drug: NBI-1065890",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Participants will receive placebo matching NBI-1065890.",[19],"Drug: Placebo",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Oral administration",[9],null,{"type":22,"name":15,"description":23,"armGroupLabels":27,"otherNames":25},[15],[29],{"name":30,"affiliation":5,"role":31},"Clinical Development Lead","STUDY_DIRECTOR",[33],{"name":34,"role":35,"phone":36,"phoneExt":25,"email":37},"Neurocrine Medical Information Call Center","CONTACT","1-877-641-3461","medinfo@neurocrine.com",[39,53,62,70,78,86,94,102,111,119,127,135,143,151,160,169,178,187],{"facility":40,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":25},"Neurocrine Clinical Site","RECRUITING","Bryant","Arkansas","72022","United States","US",{"type":48,"coordinates":49},"Point",[50,51],-92.48905,34.59593,{"lat":51,"lon":50},{"facility":40,"status":41,"city":54,"state":55,"zip":56,"country":45,"countryCode":46,"cosmosGeoPoint":57,"geoPoint":61,"contacts":25},"Chino","California","91710",{"type":48,"coordinates":58},[59,60],-117.68894,34.01223,{"lat":60,"lon":59},{"facility":40,"status":41,"city":63,"state":55,"zip":64,"country":45,"countryCode":46,"cosmosGeoPoint":65,"geoPoint":69,"contacts":25},"Fountain Valley","92708",{"type":48,"coordinates":66},[67,68],-117.95367,33.70918,{"lat":68,"lon":67},{"facility":40,"status":41,"city":71,"state":55,"zip":72,"country":45,"countryCode":46,"cosmosGeoPoint":73,"geoPoint":77,"contacts":25},"Huntington Beach","92648",{"type":48,"coordinates":74},[75,76],-117.99923,33.6603,{"lat":76,"lon":75},{"facility":40,"status":41,"city":79,"state":55,"zip":80,"country":45,"countryCode":46,"cosmosGeoPoint":81,"geoPoint":85,"contacts":25},"Long Beach","90807",{"type":48,"coordinates":82},[83,84],-118.18923,33.76696,{"lat":84,"lon":83},{"facility":40,"status":41,"city":87,"state":55,"zip":88,"country":45,"countryCode":46,"cosmosGeoPoint":89,"geoPoint":93,"contacts":25},"Temecula","92591",{"type":48,"coordinates":90},[91,92],-117.14836,33.49364,{"lat":92,"lon":91},{"facility":40,"status":41,"city":95,"state":55,"zip":96,"country":45,"countryCode":46,"cosmosGeoPoint":97,"geoPoint":101,"contacts":25},"Torrance","90501",{"type":48,"coordinates":98},[99,100],-118.34063,33.83585,{"lat":100,"lon":99},{"facility":40,"status":41,"city":103,"state":104,"zip":105,"country":45,"countryCode":46,"cosmosGeoPoint":106,"geoPoint":110,"contacts":25},"Boca Raton","Florida","33486",{"type":48,"coordinates":107},[108,109],-80.0831,26.35869,{"lat":109,"lon":108},{"facility":40,"status":41,"city":112,"state":104,"zip":113,"country":45,"countryCode":46,"cosmosGeoPoint":114,"geoPoint":118,"contacts":25},"Bonita Springs","34134",{"type":48,"coordinates":115},[116,117],-81.7787,26.33981,{"lat":117,"lon":116},{"facility":40,"status":41,"city":120,"state":104,"zip":121,"country":45,"countryCode":46,"cosmosGeoPoint":122,"geoPoint":126,"contacts":25},"Hialeah","33012",{"type":48,"coordinates":123},[124,125],-80.27811,25.8576,{"lat":125,"lon":124},{"facility":40,"status":41,"city":128,"state":104,"zip":129,"country":45,"countryCode":46,"cosmosGeoPoint":130,"geoPoint":134,"contacts":25},"Miami","33176",{"type":48,"coordinates":131},[132,133],-80.19366,25.77427,{"lat":133,"lon":132},{"facility":40,"status":41,"city":136,"state":104,"zip":137,"country":45,"countryCode":46,"cosmosGeoPoint":138,"geoPoint":142,"contacts":25},"Orange City","32763",{"type":48,"coordinates":139},[140,141],-81.29867,28.94888,{"lat":141,"lon":140},{"facility":40,"status":41,"city":144,"state":104,"zip":145,"country":45,"countryCode":46,"cosmosGeoPoint":146,"geoPoint":150,"contacts":25},"Tampa","33629",{"type":48,"coordinates":147},[148,149],-82.45843,27.94752,{"lat":149,"lon":148},{"facility":40,"status":41,"city":152,"state":153,"zip":154,"country":45,"countryCode":46,"cosmosGeoPoint":155,"geoPoint":159,"contacts":25},"Marietta","Georgia","30060",{"type":48,"coordinates":156},[157,158],-84.54993,33.9526,{"lat":158,"lon":157},{"facility":40,"status":41,"city":161,"state":162,"zip":163,"country":45,"countryCode":46,"cosmosGeoPoint":164,"geoPoint":168,"contacts":25},"Lincoln","Nebraska","68526",{"type":48,"coordinates":165},[166,167],-96.66696,40.8,{"lat":167,"lon":166},{"facility":40,"status":41,"city":170,"state":171,"zip":172,"country":45,"countryCode":46,"cosmosGeoPoint":173,"geoPoint":177,"contacts":25},"Beachwood","Ohio","44122",{"type":48,"coordinates":174},[175,176],-81.50873,41.4645,{"lat":176,"lon":175},{"facility":40,"status":41,"city":179,"state":180,"zip":181,"country":45,"countryCode":46,"cosmosGeoPoint":182,"geoPoint":186,"contacts":25},"Fort Worth","Texas","76104",{"type":48,"coordinates":183},[184,185],-97.32085,32.72541,{"lat":185,"lon":184},{"facility":40,"status":41,"city":188,"state":180,"zip":189,"country":45,"countryCode":46,"cosmosGeoPoint":190,"geoPoint":194,"contacts":25},"Houston","77030",{"type":48,"coordinates":191},[192,193],-95.36327,29.76328,{"lat":193,"lon":192},{"type":196,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100621041","phase-2-efficacy-safety-and-tolerability-of-nbi-1065890-versus-placebo-in-adults-with-tardive-dyskinesia-100621041",false,"NCT07365462","Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia","A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NBI-1065890 in Adult Participants With Tardive Dyskinesia","Key Inclusion Criteria:\n\n* Medically confirmed diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or major depressive disorder (MDD) as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) for at least 3 months prior to screening.\n* Medically confirmed diagnosis of neuroleptic-induced TD as defined in the DSM-5 for at least 3 months prior to screening.\n* Moderate or severe TD (AIMS Item 8, severity of abnormal movement overall) as assessed by a blinded, external AIMS video reviewer using a video recording of the participant's AIMS assessment administered at the clinical site by a blinded, certified site AIMS rater. The AIMS dyskinesia total score (sum of Items 1 to 7) must be ≥6 as assessed by the blinded, external AIMS video reviewer.\n\nKey Exclusion Criteria:\n\n* Comorbid parkinsonism (drug-induced or otherwise) or more than a minimal level of extrapyramidal signs\u002Fsymptoms, as documented by a score on the Modified Simpson-Angus Scale (mSAS) (excluding Items 8 and 10) \\>6 at screening or Day -1 (baseline) or a score \\>3 in any one item (excluding Items 8 and 10).\n* Barnes Akathisia Rating Scale (BARS) global clinical assessment score ≥2 at screening or Day -1.\n* Brief Psychiatric Rating Scale (BPRS) total score ≥50 at screening or Day -1.\n* Hospitalized for schizophrenia, schizoaffective disorder, bipolar disorder, or MDD within 6 months of screening.\n* Participant has an unstable medical condition or unstable chronic disease.\n* Any known history of neuroleptic malignant syndrome (NMS).\n\nNote: Other protocol-defined inclusion and exclusion criteria may apply.","ALL","18 Years","75 Years",{"count":208,"type":209},100,"ESTIMATED","INTERVENTIONAL",[212],"PHASE2","The primary objective of this study is to evaluate the efficacy of NBI-1065890 compared with placebo for the treatment of tardive dyskinesia (TD) in adult participants.",[215],"Tardive Dyskinesia",[215,9],"2026-06-19",{"date":219,"type":220},"2026-06-23","ACTUAL",{"date":222,"type":220},"2026-02-06",{"date":224,"type":209},"2027-03",{"name":5,"class":6},18]